دورية أكاديمية

Tea Tree Oil Nanoemulsion-Based Hydrogel Vehicle for Enhancing Topical Delivery of Neomycin.

التفاصيل البيبلوغرافية
العنوان: Tea Tree Oil Nanoemulsion-Based Hydrogel Vehicle for Enhancing Topical Delivery of Neomycin.
المؤلفون: Elsewedy HS; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Alhofuf 36362, Al-Ahsa, Saudi Arabia., Shehata TM; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Alhofuf 36362, Al-Ahsa, Saudi Arabia.; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt., Soliman WE; Department of Biomedical Sciences, College of Clinical Pharmacy, King Faisal University, Alhofuf 36362, Al-Ahsa, Saudi Arabia.; Department of Microbiology and Immunology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Mansoura 11152, Egypt.
المصدر: Life (Basel, Switzerland) [Life (Basel)] 2022 Jul 07; Vol. 12 (7). Date of Electronic Publication: 2022 Jul 07.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101580444 Publication Model: Electronic Cited Medium: Print ISSN: 2075-1729 (Print) Linking ISSN: 20751729 NLM ISO Abbreviation: Life (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, 2011-
مستخلص: The present investigation aims to improve the antimicrobial influence of certain antibacterial drugs, namely, neomycin (NEO), exploiting the benefits of natural oils such as tea tree oil (TTO). Therefore, a distinctive nanolipid formulation, namely, a nanoemulsion (NE), was developed using a Central Composite Factorial Design (CCD) approach depending on the amount of TTO and tween 80 as surfactant. The optimized NEO-NE formula exhibiting minimum globular size and maximum in vitro release was selected. For efficient topical delivery, NEO-NE was incorporated into a pre-formulated hydrogel. The developed NEO-NE-hydrogel was characterized by its physical characteristics such as pH, viscosity, and spreadability. Next, it was tested for stability under different conditions for 3 months. Ultimately, an irritation test was conducted followed by an antibacterial examination. The preparation demonstrated acceptable properties to be successfully applied topically. It showed non-significant changes in stability in both conditions up to 3 months storage when compared to a fresh preparation. It exhibited no irritation when applied on hairless animal skin. Finally, TTO revealed a good inhibition for the bacterial growth that could improve the influence of NEO antibacterial activity, indicating the efficiency of NE containing NEO prepared with TTO to be a promising antibacterial nanocarrier.
References: Int J Nanomedicine. 2018 Jan 31;13:669-680. (PMID: 29440893)
J Antibiot (Tokyo). 2009 Oct;62(10):539-44. (PMID: 19629142)
Nanoscale. 2021 Jun 28;13(24):10748-10764. (PMID: 34132312)
Int J Nanomedicine. 2021 Feb 22;16:1457-1472. (PMID: 33654396)
Pharmaceutics. 2015 Oct 22;7(4):438-70. (PMID: 26506371)
Cancers (Basel). 2020 Sep 28;12(10):. (PMID: 32998391)
Int J Nanomedicine. 2018 Apr 27;13:2571-2584. (PMID: 29731632)
ScientificWorldJournal. 2015;2015:495271. (PMID: 25853145)
AAPS PharmSciTech. 2021 Nov 11;22(8):269. (PMID: 34762193)
Pharm Res. 2004 Jul;21(7):1192-9. (PMID: 15290859)
Clin Microbiol Rev. 2006 Jan;19(1):50-62. (PMID: 16418522)
3 Biotech. 2015 Apr;5(2):123-127. (PMID: 28324579)
J Nanobiotechnology. 2018 Sep 19;16(1):71. (PMID: 30231877)
Gels. 2022 May 19;8(5):. (PMID: 35621616)
J Med Chem. 2008 Dec 11;51(23):7563-73. (PMID: 19012394)
Expert Opin Drug Deliv. 2010 Nov;7(11):1303-27. (PMID: 20961206)
Polymers (Basel). 2021 Feb 14;13(4):. (PMID: 33672981)
Drug Dev Ind Pharm. 2020 Feb;46(2):329-342. (PMID: 31976777)
Antimicrob Agents Chemother. 2015 Nov 23;60(2):862-72. (PMID: 26596945)
Gels. 2022 Apr 15;8(4):. (PMID: 35448146)
Int J Nanomedicine. 2014 Nov 26;9:5503-14. (PMID: 25473287)
Pharmaceutics. 2020 Dec 17;12(12):. (PMID: 33348692)
Turk J Pharm Sci. 2021 Sep 1;18(4):465-475. (PMID: 34496553)
J Appl Microbiol. 2000 Jan;88(1):170-5. (PMID: 10735256)
Saudi Pharm J. 2012 Jan;20(1):63-7. (PMID: 23960777)
Polymers (Basel). 2021 Mar 17;13(6):. (PMID: 33802819)
Pharmaceutics. 2019 Mar 21;11(3):. (PMID: 30901930)
Antioxidants (Basel). 2021 Jan 10;10(1):. (PMID: 33435216)
Microorganisms. 2022 Jan 01;10(1):. (PMID: 35056543)
Curr Opin Infect Dis. 2012 Dec;25(6):626-33. (PMID: 23041772)
Skin Res Technol. 2019 Sep;25(5):725-734. (PMID: 31062432)
Plants (Basel). 2021 Oct 04;10(10):. (PMID: 34685914)
Turk Pediatri Ars. 2014 Sep 01;49(3):231-7. (PMID: 26078668)
Gels. 2021 Nov 18;7(4):. (PMID: 34842709)
Pharmaceuticals (Basel). 2022 Feb 03;15(2):. (PMID: 35215303)
Drug Des Devel Ther. 2016 Aug 02;10:2467-75. (PMID: 27536067)
Int J Mol Sci. 2012 Oct 11;13(10):13049-64. (PMID: 23202937)
AAPS PharmSciTech. 2019 Mar 4;20(3):134. (PMID: 30830481)
Can J Surg. 1979 May;22(3):274-7. (PMID: 436029)
Gels. 2022 Apr 22;8(5):. (PMID: 35621560)
Indian J Pharm Sci. 2009 Jul;71(4):421-7. (PMID: 20502548)
Pharmaceutics. 2021 Jul 12;13(7):. (PMID: 34371759)
Eur J Pharm Biopharm. 2017 Jun;115:31-38. (PMID: 28216002)
Expert Rev Anti Infect Ther. 2020 Jan;18(1):5-15. (PMID: 31847614)
Indian J Dermatol. 2021 Mar-Apr;66(2):117-125. (PMID: 34188265)
Gels. 2021 Dec 25;8(1):. (PMID: 35049551)
Curr Drug Deliv. 2019;16(5):444-460. (PMID: 30714524)
Pharmaceutics. 2021 Jul 11;13(7):. (PMID: 34371755)
معلومات مُعتمدة: [Project No. GRANT690]. Annual Funding track by the Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia [Project No. GRANT690].
فهرسة مساهمة: Keywords: antibacterial; nanoemulsion; neomycin; optimization; tea tree oil; topical delivery
تواريخ الأحداث: Date Created: 20220727 Latest Revision: 20220731
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9317510
DOI: 10.3390/life12071011
PMID: 35888099
قاعدة البيانات: MEDLINE
الوصف
تدمد:2075-1729
DOI:10.3390/life12071011